# An Evaluation of PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic Dermatitis

> **NCT01826461** · PHASE2 · COMPLETED · sponsor: **PreCision Dermatology, Inc.** · enrollment: 151 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** PDI-192
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT01826461
- **Lead sponsor:** PreCision Dermatology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2014-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01826461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01826461, "An Evaluation of PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic Dermatitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01826461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*